Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Gains $2.7M for Women's Cancer Collaboration

NEW YORK (GenomeWeb News) — Belgium-based OncoMethylome Sciences has received a €1.95 million ($2.7 million) grant from the Belgian government to work on a collaborative project that will study women’s cancers and cancer vaccines, the company said today.
 
The four-year program, which includes research partners the University of Liege and GlaxoSmithKline, is funded with €3.5 million, of which €1.95 million goes to OncoMethylome and €1.55 million goes to the University of Liege.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.